Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Institute of Spine & Pain, formerly known as the National Institute of Pain, is a specialized medical organization and clinical research center based in Lutz, Florida. Founded in 2006 by Dr. Sunil J. Panchal, the institute provides comprehensive interventional pain management, spine care, and orthopedic therapies. It is recognized for its significant contributions to clinical research, serving as a site for Phase 1 through Phase 4 clinical trials for major pharmaceutical companies, including Janssen and Nektar Therapeutics. The center utilizes a multidisciplinary approach to treat a wide range of conditions such as chronic back pain, neuropathic pain, and cancer-related pain, employing advanced modalities like neuromodulation and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Institute of Pain.